المؤلفون: Costa, Luisa, Lubrano, Ennio, Ramonda, Roberta, Chimenti, Maria Sole, Vezzù, Maristella, Perrotta, Fabio M., Del Puente, Antonio, Peluso, Rosario, Bottiglieri, Paolo, Lorenzin, Mariagrazia, Sunzini, Flavia, Darda, Md Abud, Fiocco, Ugo, Perricone, Roberto, Punzi, Leonardo, Scarpa, Raffaele, Caso, Francesco

المساهمون: Costa, Luisa, Lubrano, Ennio, Ramonda, Roberta, Chimenti, Maria Sole, Vezzù, Maristella, Perrotta, Fabio M., Del Puente, Antonio, Peluso, Rosario, Bottiglieri, Paolo, Lorenzin, Mariagrazia, Sunzini, Flavia, Darda, Md Abud, Fiocco, Ugo, Perricone, Roberto, Punzi, Leonardo, Scarpa, Raffaele, Caso, Francesco

مصطلحات موضوعية: Drug discontinuation rate, Elderly PsA patient, MDA, TNF-α blocker, Adalimumab, Aged, Antirheumatic Agent, Arthritis, Psoriatic, Biological Product, Etanercept, Female, Human, Infliximab, Italy, Male, Middle Aged, Remission Induction, Severity of Illness Index, Treatment Outcome, Tumor Necrosis Factor-alpha, Rheumatology

وصف الملف: ELETTRONICO

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/28589323; info:eu-repo/semantics/altIdentifier/wos/WOS:000406182900013; volume:36; issue:8; firstpage:1797; lastpage:1802; numberofpages:6; journal:CLINICAL RHEUMATOLOGY; http://hdl.handle.net/11577/3274696Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85020292480; link.springer.de/link/service/journals/10067/index.htm

الإتاحة: https://doi.org/10.1007/s10067-017-3697-3Test
http://hdl.handle.net/11577/3274696Test

المؤلفون: CASO, FRANCESCO, DEL PUENTE, ANTONIO, PELUSO, ROSARIO, SCARPA, RAFFAELE, COSTA, LUISA, Lubrano, Ennio, Caso, Paolo, Foglia, Francesca, Benigno, Carolina, Girolimetto, Nicolò, Bottiglieri, Paolo

المساهمون: Caso, Francesco, Lubrano, Ennio, DEL PUENTE, Antonio, Caso, Paolo, Peluso, Rosario, Foglia, Francesca, Benigno, Carolina, Girolimetto, Nicolò, Bottiglieri, Paolo, Scarpa, Raffaele, Costa, Luisa

مصطلحات موضوعية: adalimumab, anti-TNF-a, certolizumab, etanercept, golimumab, infliximab, psoriatic arthriti, therapy, TNF-a, Immunology and Allergy, Immunology

العلاقة: info:eu-repo/semantics/altIdentifier/wos/WOS:000370829800001; volume:12; issue:3; firstpage:315; lastpage:331; numberofpages:17; journal:EXPERT REVIEW OF CLINICAL IMMUNOLOGY; http://hdl.handle.net/11588/648252Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84959567989

الإتاحة: https://doi.org/10.1586/1744666X.2016.1117941Test
http://hdl.handle.net/11588/648252Test

المؤلفون: DI MINNO, matteo nicola dario, PELUSO, ROSARIO, LUPOLI, ROBERTA, SCARPA, RAFFAELE, DI MINNO, GIOVANNI, TARANTINO, GIOVANNI, Iervolino S, Russolillo A, CaRRDS Study Group

المساهمون: DI MINNO, matteo nicola dario, Iervolino, S, Peluso, Rosario, Russolillo, A, Lupoli, Roberta, Scarpa, Raffaele, DI MINNO, Giovanni, Tarantino, Giovanni, CaRRDS Study, Group

المصدر: The Journal of Rheumatology. 39:1042-1046

مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Immunology, Arthritis, Antibodies, Monoclonal, Humanized, Severity of Illness Index, Gastroenterology, Receptors, Tumor Necrosis Factor, Etanercept, Psoriatic arthritis, Rheumatology, Internal medicine, medicine, Adalimumab, Humans, Immunology and Allergy, Prospective Studies, Prospective cohort study, Ultrasonography, Tumor Necrosis Factor-alpha, business.industry, Arthritis, Psoriatic, Antibodies, Monoclonal, Middle Aged, medicine.disease, Infliximab, Fatty Liver, Endocrinology, Antirheumatic Agents, Immunoglobulin G, Female, Liver function, Steatosis, business, Follow-Up Studies, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6719f20fd540e260fc2d57b6031735feTest
https://doi.org/10.3899/jrheum.111391Test

المؤلفون: DI MINNO, MATTEO, IERVOLINO, SALVATORE, ZINCARELLI, CARMELA, LUPOLI, ROBERTA, AMBROSINO, PASQUALE, Pizzicato, Paolo, Di Minno, Alessandro, Pappone, Nicola, PELUSO, ROSARIO

المساهمون: DI MINNO, Matteo, Iervolino, Salvatore, Zincarelli, Carmela, Lupoli, Roberta, Ambrosino, Pasquale, Pizzicato, Paolo, Di Minno, Alessandro, Pappone, Nicola, Peluso, Rosario

مصطلحات موضوعية: cardiovascular risk factor, Etanercept, psoriatic arthriti, Pharmacology (medical)

العلاقة: info:eu-repo/semantics/altIdentifier/wos/WOS:000366671800002; volume:14; issue:12; firstpage:1905; lastpage:1913; numberofpages:9; journal:EXPERT OPINION ON DRUG SAFETY; http://hdl.handle.net/11588/633393Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84951905573

الإتاحة: https://doi.org/10.1517/14740338.2015.1111870Test
http://hdl.handle.net/11588/633393Test

المؤلفون: CASO, FRANCESCO, MORISCO, FILOMENA, DEL PUENTE, ANTONIO, PELUSO, ROSARIO, SCARPA, RAFFAELE, COSTA, LUISA, Cantarini, Luca, Ramonda, Roberta, Fiocco, Ugo, Lubrano, Ennio, Caso, Paolo, Galeazzi, Mauro, Punzi, Leonardo

المساهمون: Caso, Francesco, Cantarini, Luca, Morisco, Filomena, DEL PUENTE, Antonio, Ramonda, Roberta, Fiocco, Ugo, Lubrano, Ennio, Peluso, Rosario, Caso, Paolo, Galeazzi, Mauro, Punzi, Leonardo, Scarpa, Raffaele, Costa, Luisa

مصطلحات موضوعية: TNF-α inhibitor, adalimumab, etanercept, hepatitis C virus infection, psoriatic arthriti, Anti-Inflammatory Agent, Antibodies, Monoclonal, Humanized, Antirheumatic Agent, Arthritis, Psoriatic, Disease Management, Hepatitis C, Human, Immunoglobulin Fab Fragment, Polyethylene Glycol, Randomized Controlled Trials as Topic, Tumor Necrosis Factor-alpha

العلاقة: info:eu-repo/semantics/altIdentifier/wos/WOS:000352703300005; volume:15; issue:5; firstpage:641-50; lastpage:650; journal:EXPERT OPINION ON BIOLOGICAL THERAPY; http://hdl.handle.net/11588/612539Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84927646270

الإتاحة: https://doi.org/10.1517/14712598.2015.1011616Test
http://hdl.handle.net/11588/612539Test

المؤلفون: SCARPA, RAFFAELE, PELUSO, ROSARIO, M. Atteno

المساهمون: AA VARI, Scarpa, Raffaele, Peluso, Rosario, M., Atteno

مصطلحات موضوعية: etanercept, artrite psoriasica, farmaci inibitori del TNF

وصف الملف: STAMPA

العلاقة: info:eu-repo/semantics/altIdentifier/isbn/111111111111111; ispartofbook:The New Frontier in Rheumatology. Gli anti-TNF sono simili o sono farmaci diversi?; volume:4; 1/2; firstpage:20; lastpage:25; http://hdl.handle.net/11588/337872Test

الإتاحة: http://hdl.handle.net/11588/337872Test

المؤلفون: Leonardo Punzi, Roberto Perricone, Maria Sole Chimenti, Rosario Peluso, Flavia Sunzini, Mariagrazia Lorenzin, Abud Darda, Luisa Costa, Ugo Fiocco, Antonio Del Puente, Fabio Massimo Perrotta, Francesco Caso, Ennio Lubrano, M. Vezzù, Raffaele Scarpa, Paolo Bottiglieri, Roberta Ramonda

المساهمون: Costa, Luisa, Lubrano, Ennio, Ramonda, Roberta, Chimenti, Maria Sole, Vezzù, Maristella, Perrotta, Fabio M, DEL PUENTE, Antonio, Peluso, Rosario, Bottiglieri, Paolo, Lorenzin, Mariagrazia, Sunzini, Flavia, Darda, Md Abud, Fiocco, Ugo, Perricone, Roberto, Punzi, Leonardo, Scarpa, Raffaele, Caso, Francesco

المصدر: Clinical Rheumatology. 36:1797-1802

مصطلحات موضوعية: Male, MDA, Inflammatory arthritis, Psoriatic, Severity of Illness Index, Etanercept, 0302 clinical medicine, 030212 general & internal medicine, TNF-α blockers, Elderly PsA patient, Remission Induction, General Medicine, Middle Aged, Treatment Outcome, Italy, Antirheumatic Agents, Elderly PsA patients, Female, medicine.drug, medicine.medical_specialty, Drug discontinuation rate, TNF-α blockers, Rheumatology, 03 medical and health sciences, Psoriatic arthritis, Internal medicine, medicine, Adalimumab, Humans, Adverse effect, Aged, 030203 arthritis & rheumatology, Biological Products, Tumor Necrosis Factor-alpha, business.industry, Arthritis, Arthritis, Psoriatic, medicine.disease, Infliximab, Golimumab, Surgery, Settore MED/16 - Reumatologia, Regimen, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aae4621b1a7ab63cb89dbc9c7a0b9b44Test
https://doi.org/10.1007/s10067-017-3697-3Test

المؤلفون: Carmela Zincarelli, Rosario Peluso, N. Pappone, Matteo Nicola Dario Di Minno, Salvatore Iervolino, Alessandro Di Minno, Paolo Pizzicato, Pasquale Ambrosino, Roberta Lupoli

المساهمون: DI MINNO, Matteo, Iervolino, Salvatore, Zincarelli, Carmela, Lupoli, Roberta, Ambrosino, Pasquale, Pizzicato, Paolo, Di Minno, Alessandro, Pappone, Nicola, Peluso, Rosario

المصدر: Expert Opinion on Drug Safety. 14:1905-1913

مصطلحات موضوعية: medicine.medical_specialty, Pathology, psoriatic arthriti, Population, Inflammation, Systemic inflammation, Carotid Intima-Media Thickness, Etanercept, Psoriatic arthritis, Risk Factors, Internal medicine, medicine, Humans, cardiovascular risk factor, Pharmacology (medical), In patient, education, Diseases database, internet.website, internet, education.field_of_study, business.industry, Anti-Inflammatory Agents, Non-Steroidal, Arthritis, Psoriatic, General Medicine, medicine.disease, Cardiovascular Diseases, Antirheumatic Agents, Hemostasis, medicine.symptom, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::91b4adbb2f335c96eee796bc35b9da52Test
https://doi.org/10.1517/14740338.2015.1111870Test

المؤلفون: Nicolò Girolimetto, Carolina Benigno, Luisa Costa, Paolo Caso, Ennio Lubrano, Raffaele Scarpa, Antonio Del Puente, Francesca Foglia, Francesco Caso, Paolo Bottiglieri, Rosario Peluso

المساهمون: Caso, Francesco, Lubrano, Ennio, DEL PUENTE, Antonio, Caso, Paolo, Peluso, Rosario, Foglia, Francesca, Benigno, Carolina, Girolimetto, Nicolò, Bottiglieri, Paolo, Scarpa, Raffaele, Costa, Luisa

مصطلحات موضوعية: 0301 basic medicine, anti-TNF-a, psoriatic arthriti, TNF-a, Immunology, Anti-Inflammatory Agents, Certolizumab, Receptors, Tumor Necrosis Factor, Dactylitis, Etanercept, 03 medical and health sciences, Psoriatic arthritis, 0302 clinical medicine, adalimumab, medicine, Adalimumab, Animals, Humans, Immunology and Allergy, Certolizumab pegol, golimumab, Randomized Controlled Trials as Topic, Skin, 030203 arthritis & rheumatology, psoriatic arthritis, certolizumab, therapy, business.industry, Tumor Necrosis Factor-alpha, Arthritis, Psoriatic, Antibodies, Monoclonal, etanercept, infliximab, medicine.disease, Antibodies, Neutralizing, Golimumab, Infliximab, 030104 developmental biology, Disease Progression, Immunotherapy, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd703d6bd6005e4ac6ac3a2674867457Test
http://hdl.handle.net/11588/648252Test

المؤلفون: Antonio Del Puente, Raffaele Scarpa, Francesco Caso, Roberta Ramonda, Ennio Lubrano, Mauro Galeazzi, Leonardo Punzi, Luisa Costa, Ugo Fiocco, Paolo Caso, Rosario Peluso, Luca Cantarini, Filomena Morisco

المساهمون: Caso, Francesco, Cantarini, Luca, Morisco, Filomena, DEL PUENTE, Antonio, Ramonda, Roberta, Fiocco, Ugo, Lubrano, Ennio, Peluso, Rosario, Caso, Paolo, Galeazzi, Mauro, Punzi, Leonardo, Scarpa, Raffaele, Costa, Luisa

مصطلحات موضوعية: Oncology, medicine.medical_specialty, psoriatic arthriti, Hepatitis C virus, Clinical Biochemistry, Anti-Inflammatory Agents, medicine.disease_cause, Antibodies, Monoclonal, Humanized, Polyethylene Glycol, Etanercept, Polyethylene Glycols, Psoriatic arthritis, Immunoglobulin Fab Fragments, TNF-α inhibitors, adalimumab, etanercept, hepatitis C virus infection, psoriatic arthritis, Internal medicine, Psoriasis, Drug Discovery, medicine, Adalimumab, Humans, Randomized Controlled Trials as Topic, Pharmacology, Immunoglobulin Fab Fragment, business.industry, Tumor Necrosis Factor-alpha, TNF-α inhibitor, Arthritis, Psoriatic, Hepatitis C virus infection, Antirheumatic Agent, Antibodies, Monoclonal, Disease Management, medicine.disease, Hepatitis C, Infliximab, Anti-Inflammatory Agent, Tnf α inhibitors, Concomitant, Antirheumatic Agents, Immunology, Certolizumab Pegol, business, Medical literature, medicine.drug, Human

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ba9ffae2d1ba5897d1673340fff7fecTest
http://hdl.handle.net/11365/976323Test